Cargando…
Development of a novel 3-month drug releasing risperidone microspheres
OBJECTIVE: The purpose of this study was to develop an ideal microsphere formulation of risperidone that would prolong the drug release for 3 months in vivo and avoid the need for co-administration of oral tablets. MATERIALS AND METHODS: Polycaprolactones (PCL) were used as polymers to prepare micro...
Autores principales: | Yerragunta, Bhanusree, Jogala, Satheesh, Chinnala, Krishna Mohan, Aukunuru, Jithan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333626/ https://www.ncbi.nlm.nih.gov/pubmed/25709335 http://dx.doi.org/10.4103/0975-7406.148777 |
Ejemplares similares
-
Development of novel risperidone implants using blends of polycaprolactones and in vitro in vivo correlation studies
por: Navitha, Aerrolla, et al.
Publicado: (2014) -
Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin
por: Jogala, Satheesh, et al.
Publicado: (2015) -
Development and evaluation of a novel biodegradable sustained release microsphere formulation of paclitaxel intended to treat breast cancer
por: Shiny, Jacob, et al.
Publicado: (2013) -
Development of Risperidone PLGA Microspheres
por: D'Souza, Susan, et al.
Publicado: (2014) -
Preparation, Characterization and in vivo Evaluation of Parenteral Sustained Release Microsphere Formulation of Zopiclone
por: Swapna, N, et al.
Publicado: (2010)